Evidence map›Paper›PMID 42035472›Full record

ArticleVirulence2026

3C suppresses PINK1-mediated mitophagy and contributes to coxsackievirus B3 replication.

Tingjun Liu, Ao Wan, Yinhai Xu, Hongxiang Lu, Yiwei Xie, Han Wu, Jiang Wang, Hua Wang, Tingting Hao, Yonggen Zhang and 3 more

Abstract read
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tingjun LiuDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Ao WanSchool of Medical Technology, Xuzhou Medical University, Xuzhou, China.
Yinhai XuDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Hongxiang LuDepartment of Laboratory Medicine, Jiangning Hospital Affiliated to Nanjng Medical University, Nanjing, China.
Yiwei XieDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Han WuSchool of Medical Technology, Xuzhou Medical University, Xuzhou, China.
Jiang WangSchool of Medical Technology, Xuzhou Medical University, Xuzhou, China.
Hua WangDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
Tingting HaoDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yonggen ZhangDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Jinfeng XuDepartment of Clinical Laboratory, Zhenjiang Center for Disease Control and Prevention, Zhenjiang, Jiangsu, China.
Hongxing ShenDepartment of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.ORCID 0000-0001-7311-5464
Shibao LiDepartment of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.ORCID 0000-0002-4026-4508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral myocarditis (VM) is a cardiac inflammatory condition caused by viral infection and serves as a critical precursor to life-threatening complications, such as dilated cardiomyopathy and heart failure. Coxsackievirus B3 (CVB3), a predominant etiological agent of VM, lacks targeted therapeutic interventions despite ongoing antiviral development. Mitophagy is a selective mitochondrial quality control mechanism mediated by PINK1. It has two key roles: maintaining mitochondrial homeostasis and regulating innate antiviral immunity. Here, we employed single-cell RNA sequencing to reveal a significant correlation between impaired mitophagy and cardiomyocyte pathology in CVB3-induced myocarditis. We demonstrated that CVB3 infection suppresses PINK1-dependent mitophagy, while the attenuation of PINK1 reciprocally enhances CVB3 replication. Mechanistically, CVB3 non-structural protein 3C promotes the degradation of mitochondrial antiviral signaling protein (MAVS). MAVS interacts with PINK1 to form a regulatory loop: PINK1 deficiency boosts MAVS reduction, which further promotes viral replication and worsens myocardial injury. Furthermore, we identify the transcription factor FOSL1 as a novel negative regulator of PINK1 transcription through direct promoter binding. Collectively, these findings show that the 3C/FOSL1/PINK1/MAVS signaling axis is a key mechanism in CVB3 pathogenesis. We propose innovative therapeutic targets for viral myocarditis through restoration of mitochondrial homeostasis and modulation of host-virus interactions.

Indexed as

Coxsackievirus InfectionsEnterovirus B, HumanMitophagyProtein KinasesViral ProteinsVirus ReplicationAdaptor Proteins, Signal TransducingAnimalsHost-Pathogen InteractionsHumansMyocarditisMyocytes, CardiacPTEN-Induced Putative KinaseSignal TransductionAdaptor Proteins, Signal TransducingMAVS protein, humanProtein KinasesPTEN-Induced Putative KinaseViral Proteinscoxsackievirus B3MAVSmitophagyPINK1Viral myocarditis

Identifiers

PMID42035472
PMCPMC13114115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.